Skip to main content

Market Overview

Why Abbott Is Trading Lower Today

Share:
Why Abbott Is Trading Lower Today

Abbott Laboratories (NYSE: ABT) is trading lower Tuesday morning after the company issued an updated outlook for 2021 below estimates. 

What Happened: Abbott announced an update to its financial outlook for full-year 2021 as a result of significantly lower COVID-19 diagnostic testing demand. 

Abbott expects full-year adjusted earnings-per-share to be $4.30 to $4.50, which came in below the estimate of $5.04 per share.

See also: Best Pharma ETFs

The company attributed the decreased testing demand to significant reductions in COVID-19 cases, accelerated rollout of COVID-19 vaccines globally and U.S. health authority guidance on testing for fully vaccinated individuals.

"We've recently seen a rapid decline in COVID-19 testing demand and anticipate this trend will continue, which led us to adjust our full-year guidance. At the same time, excluding COVID-19 tests, our organic base business growth is accelerating, we continue to see improving end-markets and our new product pipeline continues to be highly productive," said Robert Ford, president and CEO of Abbott.

Price Action: Abbott traded as high as $128.54 and as low as $86.16 over a 52-week period. 

At last check, the stock was down 5% at $110.67.

Photo courtesy of Abbott.

 

Related Articles (ABT)

View Comments and Join the Discussion!

Posted-In: Robert Ford why it's movingNews Guidance Movers Trading Ideas

Need corporate guidance data?
Click here to see licensing options.
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com